Extract from the Register of European Patents

EP About this file: EP3067064

EP3067064 - MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.03.2021
Database last updated on 07.03.2026
FormerThe patent has been granted
Status updated on  10.04.2020
FormerGrant of patent is intended
Status updated on  15.12.2019
FormerExamination is in progress
Status updated on  16.02.2018
FormerRequest for examination was made
Status updated on  20.03.2017
Most recent event   Tooltip19.03.2021No opposition filed within time limitpublished on 21.04.2021  [2021/16]
Applicant(s)For all designated states
Novavax, Inc.
21 Firstfield Rd
Gaithersburg, MD 20878 / US
[2020/20]
Former [2016/37]For all designated states
Novavax, Inc.
9920 Belward Campus Drive
Rockville, MD 20850 / US
Inventor(s)01 / PUSHKO, Peter
Novavax, Inc.
21 Firstfield Rd
Gaithersburg, MD 20878 / US
02 / WU, Yingyun
Novavax, Inc.
21 Firstfield Rd
Gaithersburg, MD 20878 / US
03 / MASSARE, Michael
Novavax, Inc.
21 Firstfield Rd
Gaithersburg, MD 20878 / US
04 / LIU, Ye
Novavax, Inc.
21 Firstfield Rd
Gaithersburg, MD 20878 / US
05 / SMITH, Gale
Novavax, Inc.
21 Firstfield Rd
Gaithersburg, MD 20878 / US
06 / ZHOU, Bin
Novavax, Inc.
21 Firstfield Rd
Gaithersburg, MD 20878 / US
 [2020/20]
Former [2016/37]01 / PUSHKO, Peter
Novavax, Inc.
20 Firstfield Road
Gaithersburg, MD 20878 / US
02 / WU, Yingyun
Novavax, Inc.
20 Firstfield Road
Gaithersburg, MD 20878 / US
03 / MASSARE, Michael
Novavax, Inc.
20 Firstfield Road
Gaithersburg, MD 20878 / US
04 / LIU, Ye
Novavax, Inc.
20 Firstfield Road
Gaithersburg, MD 20878 / US
05 / SMITH, Gale
Novavax, Inc.
20 Firstfield Road
Gaithersburg, MD 20878 / US
06 / ZHOU, Bin
Novavax, Inc.
20 Firstfield Road
Gaithersburg, MD 20878 / US
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[N/P]
Former [2016/37]Cooley (UK) LLP
Dashwood
69 Old Broad Street
London EC2M 1QS / GB
Application number, filing date16166033.709.12.2009
[2016/37]
Priority number, dateUS20080121126P09.12.2008         Original published format: US 121126 P
US20090169077P14.04.2009         Original published format: US 169077 P
US20090224787P10.07.2009         Original published format: US 224787 P
[2016/37]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3067064
Date:14.09.2016
Language:EN
[2016/37]
Type: B1 Patent specification 
No.:EP3067064
Date:13.05.2020
Language:EN
[2020/20]
Search report(s)(Supplementary) European search report - dispatched on:EP10.08.2016
ClassificationIPC:A61K39/155
[2016/37]
CPC:
A61K39/155 (EP,US); C07K19/00 (KR); C07K14/005 (EP,CN,US);
A61K38/00 (KR); A61K39/12 (EP,CN,KR,US); A61K39/39 (US);
A61K9/0019 (US); A61K9/1075 (US); A61P31/12 (EP);
A61P31/14 (EP); A61P37/04 (EP); C12N15/09 (KR);
C12N15/62 (KR); C12N15/63 (KR); C12N7/00 (KR,US);
A61K2039/5258 (EP,CN,US); A61K2039/54 (US); A61K2039/545 (US);
A61K2039/55 (US); A61K2039/55505 (EP,CN,US); A61K2039/57 (US);
A61K2039/575 (US); A61K39/00 (EP,CN,US); C07K2319/00 (CN,US);
C12N2760/18522 (EP,CN,US); C12N2760/18523 (US); C12N2760/18534 (EP,CN,US);
C12N2760/18562 (US); C12N2760/18571 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2017/16]
Former [2016/37]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:MODIFIZIERTE RSV-F-PROTEINE UND ANWENDUNGSVERFAHREN DAFÜR[2016/37]
English:MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE[2016/37]
French:PROTÉINES F DE VRS MODIFIÉES ET LEURS MÉTHODES D'UTILISATION[2016/37]
Examination procedure19.04.2016Date on which the examining division has become responsible
14.03.2017Amendment by applicant (claims and/or description)
14.03.2017Examination requested  [2017/16]
19.02.2018Despatch of a communication from the examining division (Time limit: M04)
27.06.2018Reply to a communication from the examining division
24.10.2018Despatch of a communication from the examining division (Time limit: M06)
03.05.2019Reply to a communication from the examining division
16.08.2019Despatch of a communication from the examining division (Time limit: M02)
24.10.2019Reply to a communication from the examining division
16.12.2019Communication of intention to grant the patent
06.04.2020Fee for grant paid
06.04.2020Fee for publishing/printing paid
06.04.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09836751.9  / EP2370099
Divisional application(s)EP20171841.8  / EP3718566
Opposition(s)16.02.2021No opposition filed within time limit [2021/16]
Fees paidRenewal fee
19.04.2016Renewal fee patent year 03
19.04.2016Renewal fee patent year 04
19.04.2016Renewal fee patent year 05
19.04.2016Renewal fee patent year 06
19.04.2016Renewal fee patent year 07
27.12.2016Renewal fee patent year 08
27.12.2017Renewal fee patent year 09
31.12.2018Renewal fee patent year 10
27.12.2019Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A] WO2008133663  (US GOV HEALTH & HUMAN SERV et al.)
 [A] WO2008114149  (ID BIOMEDICAL CORP QUEBEC et al.)
 [A]   RUIZ-ARGUELLO M B ET AL: "Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, vol. 85, 1 January 2004 (2004-01-01), pages 3677 - 3687, XP007917291, ISSN: 0022-1317, DOI: 10.1099/VIR.0.80318-0

DOI:   http://dx.doi.org/10.1099/vir.0.80318-0
 [A]   ANDERSON K ET AL: "Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage", JOURNAL OF GENERAL VIROLOGY, vol. 73, no. 5, 1 May 1992 (1992-05-01), pages 1177 - 1188, XP055060308, ISSN: 0022-1317, DOI: 10.1099/0022-1317-73-5-1177

DOI:   http://dx.doi.org/10.1099/0022-1317-73-5-1177
 [T]   SMITH G ET AL: "Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats", PLOS ONE, vol. 7, no. 11, 1 January 2012 (2012-01-01), pages e50852, XP055060314, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0050852

DOI:   http://dx.doi.org/10.1371/journal.pone.0050852
by applicantWO2008114149
 US2005118191
 US4877611
 US5629021
 US6387373
 US4911928
   CALDER ET AL., VIROLOGY, vol. 271, 2000, pages 122 - 131
   WRIGLEY ET AL.: "Electron Microscopy of Proteins", vol. 5, 1986, ACADEMIC PRESS, pages: 103 - 163
   GONZALEZ-REYES ET AL., PNAS, vol. 98, no. 17, 2001, pages 9859 - 9864
   SULLENDER, W., CLINICAL MICROBIOLOGY REVIEW, vol. 13, 2000, pages 1 - 15
   WALSH ET AL., J. INFECT. DIS., vol. 155, 1987, pages 1198 - 1204
   JOHNSON, PROC. NATL. ACAD. SCI. USA, vol. 84, 1987, pages 5625 - 5629
   MORTON ET AL., VIROLOGY, vol. 311, pages 275 - 288
   CONNOLLY ET AL., PROC. NATL. ACAD. SCI. USA, vol. 103, 2006, pages 17903 - 17908
   PRINCE, G. A., PH.D. DISS., 1975
   LAMBRECHT ET AL., J. INFECT. DIS., vol. 134, 1976, pages 211 - 217
   GLEZEN ET AL., J. PEDIATR, vol. 98, 1981, pages 708 - 715
   HEMMING ET AL.: "Clinical Use of Intravenous Immunoglobulins", 1986, ACADEMIC PRESS, pages: 285 - 294
   PRINCE ET AL., VIRUS RES., vol. 3, 1985, pages 193 - 206
   PRINCE ET AL., J. VIROL., vol. 64, 1990, pages 3091 - 3092
   ALI ET AL., J. VIROL., vol. 74, 2000, pages 8709 - 19
   BERGER; KIMMEL: "Guide to Molecular Cloning Techniques, Methods in Enzymology", vol. 152, ACADEMIC PRESS, INC.
   SAMBROOK ET AL.: "Molecular Cloning--A Laboratory Manual", vol. 1-3, 2000, COLD SPRING HARBOR LABORATORY
   "Current Protocols in Molecular Biology", CURRENT PROTOCOLS
   VOGEL ET AL.: "A Compendium of Vaccine Adjuvants and Excipients"
   LEVIN, D.B. ET AL., JOURNAL OF GENERAL VIROLOGY, vol. 81, 2000, pages 2313 - 2325
   OTT ET AL., JOURNAL OF VIROLOGY, vol. 79, 2005, pages 9038 - 9045
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.